Photobiomodulation Therapy in Persons With Multiple Sclerosis

Completed · Not applicable · Has a placebo group

Conditions studied: Multiple Sclerosis, Relapsing-Remitting

In brief

This study will test whether photobiomodulation therapy improves muscle endurance and decreases inflammation in persons with relapsing-remitting multiple sclerosis. We will also investigate mechanisms for any improvements.

Key facts

Study ID

NCT03691766

Run by

Marquette University

People needed

21

Starts

2018-04-30

Expected to finish

2019-09-23

Last updated by the study team

2021-02-26

Who can join

Age: 20 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Relapsing remitting MS,
• Independent or ambulatory with minimal aid.
• Must be able to move foot (ankle dorsiflexion) at least moderately forcibly against gravity (manual muscle test score 3-5)
• Subjects must be able to walk for 6 minutes independently with no or minimal use of an assistive device.

You may not qualify if…

• No noticeable left right ankle strength asymmetry
• No exacerbations (MS attacks) or immunosuppressive therapy use within the previous 6 months
• No concurrent infection or known cardiovascular disease including having a pacemaker; or other serious medical co-morbidity including metabolic, mitochondrial, autoimmune, diseases or other co-existing neurologic conditions.
• Not involved in any clinical trial or other research that could confound results.
• Must not be pregnant
• Must not have an active diagnosis of cancer

Where it is running

• Marquette University — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.